4.5 Article

Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene

Related references

Note: Only part of the references are listed.
Article Psychology, Clinical

Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study

Ilona Hallikainen et al.

INTERNATIONAL PSYCHOGERIATRICS (2013)

Article Clinical Neurology

CERAD-neuropsychological battery in screening mild Alzheimer's disease

M. Sotaniemi et al.

ACTA NEUROLOGICA SCANDINAVICA (2012)

Article Clinical Neurology

The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease

Heidi C. Rossetti et al.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)

Article Clinical Neurology

Early Diagnosis of Alzheimer's Disease: Is MCI Too Late?

Ronald C. Petersen

CURRENT ALZHEIMER RESEARCH (2009)

Review Clinical Neurology

Consortium to establish a registry for Alzheimer's disease (CERAD): The first twenty years

Gerda G. Fillenbaum et al.

ALZHEIMERS & DEMENTIA (2008)

Article Clinical Neurology

Mild cognitive impairment and Alzheimer's disease:: An investigation of the CERAD-NP test battery

S Barth et al.

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2005)

Article Clinical Neurology

A total score for the CERAD neuropsychological battery

MJ Chandler et al.

NEUROLOGY (2005)

Article Clinical Neurology

Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred

P Pastor et al.

ANNALS OF NEUROLOGY (2003)

Article Clinical Neurology

Current concepts in mild cognitive impairment

RC Petersen et al.

ARCHIVES OF NEUROLOGY (2001)